Jiahui An

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Retraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.

Retraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 06, 2023

HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.

HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.

Journal: Oncotarget
Published: October 07, 2016

HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.

HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.

Journal: Scientific reports
Published: June 08, 2016

Inflammatory cytokine IL6 cooperates with CUDR to aggravate hepatocyte-like stem cells malignant transformation through NF-κB signaling.

Inflammatory cytokine IL6 cooperates with CUDR to aggravate hepatocyte-like stem cells malignant transformation through NF-κB signaling.

Journal: Scientific reports
Published: March 24, 2016

Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.

Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.

Journal: Oncotarget
Published: March 01, 2016

Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.

Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.

Journal: Oncotarget
Published: June 22, 2015

RETRACTED: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically

RETRACTED: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 04, 2015

miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.

miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.

Journal: Oncotarget
Published: May 19, 2015

CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.

CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.

Journal: Oncotarget
Published: March 09, 2015

LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.

LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.

Journal: Oncotarget
Published: February 06, 2015
Showing 1-10 of 10

Last Updated: 09/26/2026